We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+0.79%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$176B
AUM Growth
Cap. Flow
+$177B
Cap. Flow %
100.62%
Top 10 Hldgs %
27.59%
Holding
8,107
New
8,045
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 3.13%
2 Healthcare 1.88%
3 Financials 1.57%
4 Consumer Discretionary 1.26%
5 Energy 1.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VELT
8001
CALL
DELISTED
VELTI PLC, ST HELIER ORDINARY SHARES (JERSEY)
VELT
$32K ﹤0.01%
+23,100
New +$41.3K
LEU icon
8002
Centrus Energy
LEU
$3.72B
$31K ﹤0.01%
+390
New +$36.1K
NAK
8003
PUT
Northern Dynasty Minerals
NAK
$978M
$31K ﹤0.01%
+15,000
New +$37.2K
SOL
8004
CALL
DELISTED
Emeren Group
SOL
$31K ﹤0.01%
+2,940
New +$27.2K
CHTP
8005
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
$31K ﹤0.01%
+13,343
New +$27K
HNSN
8006
PUT
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$30K ﹤0.01%
+2,090
New +$37.1K
BSDM
8007
DELISTED
BSD MEDICAL CORP (DEL)
BSDM
$30K ﹤0.01%
+22,870
New +$28.2K
DM
8008
PUT
DELISTED
DOLAN COMPANY COMMON STOCK
DM
$30K ﹤0.01%
+18,700
New +$33.4K
VRML
8009
DELISTED
Vermillion, Inc.
VRML
$30K ﹤0.01%
+11,352
New +$24.4K
BCRX icon
8010
CALL
BioCryst Pharmaceuticals
BCRX
$2.44B
$29K ﹤0.01%
+19,000
New +$32.8K
GAU
8011
CALL
Galiano Gold
GAU
$612M
$29K ﹤0.01%
+13,800
New +$34.6K
ATHX
8012
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$29K ﹤0.01%
+688
New +$31.8K
DNN icon
8013
PUT
Denison Mines
DNN
$3.17B
$28K ﹤0.01%
+24,000
New +$29.4K
VRS
8014
DELISTED
VERSO CORP COM STK (DE)
VRS
$28K ﹤0.01%
+24,561
New +$28.6K
GENE
8015
DELISTED
Genetic Technologies Ltd.
GENE
$27K ﹤0.01%
+114
New +$29.6K
ALSK
8016
DELISTED
Alaska Communications Systems
ALSK
$27K ﹤0.01%
+15,775
New +$27.1K
SORL
8017
CALL
DELISTED
SORL Auto Parts, Inc.
SORL
$27K ﹤0.01%
+10,300
New +$28.8K
CORT icon
8018
CALL
Corcept Therapeutics
CORT
$13.2B
$26K ﹤0.01%
+15,000
New +$27K
SQNS
8019
Sequans Communications SA
SQNS
$45.9M
$26K ﹤0.01%
+173
New +$26.3K
MEET
8020
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
$26K ﹤0.01%
+16,100
New +$28.3K
MVIS icon
8021
CALL
Microvision
MVIS
$50.8M
$25K ﹤0.01%
+667
New +$24.4K
TGB
8022
CALL
Trekor Metals
TGB
$3.36B
$24K ﹤0.01%
+12,900
New +$28.4K
STV
8023
DELISTED
China Digital Tv Hldgs Co Ltd
STV
$24K ﹤0.01%
+18,259
New +$26.4K
CGR
8024
DELISTED
CLAUDE RESOURCES INC (CDA)
CGR
$24K ﹤0.01%
+107,998
New +$32.2K
COB
8025
DELISTED
COLUMBIA LABORATORIE INC
COB
$24K ﹤0.01%
+36,555
New +$24K

Similar funds

Jeff Yass's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Jeff Yass, which disclosed 8,107 positions worth $176B. Its ten largest holdings account for 28% of the portfolio.

Its largest position is State Street SPDR S&P 500 ETF Trust: 53,029,388 shares worth $8.49B.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, followed by Healthcare and Financials.

  • Jeff Yass's largest Q2 2013 buy was State Street SPDR S&P 500 ETF Trust: 53,029,388 shares worth $8.49B.
  • Jeff Yass's ten largest holdings make up 28% of its $176B portfolio in Q2 2013.
  • Jeff Yass disclosed 8,107 positions in Q2 2013, its first 13F filing on record.

Based on Susquehanna International Group's 13F filing for Q2 2013, filed 13 Aug 2013.